MEDICINAL COMPOSITION FOR IMPROVING PROGNOSIS AFTER RETURN OF SPONTANEOUS CIRCULATION
PROBLEM TO BE SOLVED: To provide a medicinal composition that is capable of improving the prognosis after the return of spontaneous circulation even after the elapse of a considerably long period of time after the return of spontaneous circulation.SOLUTION: A gaseous medicinal composition for improv...
Saved in:
| Main Authors | , , , , |
|---|---|
| Format | Patent |
| Language | English Japanese |
| Published |
06.07.2017
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | PROBLEM TO BE SOLVED: To provide a medicinal composition that is capable of improving the prognosis after the return of spontaneous circulation even after the elapse of a considerably long period of time after the return of spontaneous circulation.SOLUTION: A gaseous medicinal composition for improving the prognosis after the return of spontaneous circulation is for a human subject after the elapse of at least 30 minutes after the return of spontaneous circulation following at least 10 minutes of cardiorespiratory arrest. The medicinal composition according to the present invention contains hydrogen gas and is characterized in that human patients dosed with the medicinal composition show better prognosis after the return of spontaneous circulation than human patients not dosed with the medicinal composition.SELECTED DRAWING: None
【課題】本発明は、自己心拍再開後に相当の期間が経過した後であっても、自己心拍再開後の予後を改善することができる医薬組成物を提供することを目的とする。【解決手段】少なくとも１０分間の心肺停止後に続く自己心拍再開後３０分以上経過したヒト対象における、自己心拍再開後の予後を改善するための気体状医薬組成物が提供される。本発明の医薬組成物は、水素ガスを含み、前記医薬組成物が投与されたヒト患者群において、前記医薬組成物を投与されていないヒト患者群と比べ、自己心拍再開後の予後が改善されることを特徴とする。【選択図】なし |
|---|---|
| AbstractList | PROBLEM TO BE SOLVED: To provide a medicinal composition that is capable of improving the prognosis after the return of spontaneous circulation even after the elapse of a considerably long period of time after the return of spontaneous circulation.SOLUTION: A gaseous medicinal composition for improving the prognosis after the return of spontaneous circulation is for a human subject after the elapse of at least 30 minutes after the return of spontaneous circulation following at least 10 minutes of cardiorespiratory arrest. The medicinal composition according to the present invention contains hydrogen gas and is characterized in that human patients dosed with the medicinal composition show better prognosis after the return of spontaneous circulation than human patients not dosed with the medicinal composition.SELECTED DRAWING: None
【課題】本発明は、自己心拍再開後に相当の期間が経過した後であっても、自己心拍再開後の予後を改善することができる医薬組成物を提供することを目的とする。【解決手段】少なくとも１０分間の心肺停止後に続く自己心拍再開後３０分以上経過したヒト対象における、自己心拍再開後の予後を改善するための気体状医薬組成物が提供される。本発明の医薬組成物は、水素ガスを含み、前記医薬組成物が投与されたヒト患者群において、前記医薬組成物を投与されていないヒト患者群と比べ、自己心拍再開後の予後が改善されることを特徴とする。【選択図】なし |
| Author | SANO MOTOAKI TAMURA TOMOTAKA NISHIWAKI YOSHIKI SUZUKI AKIRA HAYASHIDA TAKASHI |
| Author_xml | – fullname: TAMURA TOMOTAKA – fullname: SANO MOTOAKI – fullname: SUZUKI AKIRA – fullname: HAYASHIDA TAKASHI – fullname: NISHIWAKI YOSHIKI |
| BookMark | eNqNi8sKwjAQAHPQg4_-w-JdsAotHkNM6kq7G_LwWorEk7SF-v9YwQ_wNIeZWYtFP_RpJWKjL6iQZA2KG8seAzKBYQfYWMd3pApmVjQrD9IE7cDpEB0BG_CWKUjSHD0odCrW8vtvxfLZvaaU_bgRO6ODuu7TOLRpGrtH6tO7vdnjIS_z_FwUpTz9FX0AVZ4zYQ |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| DocumentTitleAlternate | 自己心拍再開後の予後を改善するための医薬組成物 |
| ExternalDocumentID | JP2017119667A |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_JP2017119667A3 |
| IEDL.DBID | EVB |
| IngestDate | Fri Aug 08 03:41:46 EDT 2025 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English Japanese |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_JP2017119667A3 |
| Notes | Application Number: JP20160147419 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170706&DB=EPODOC&CC=JP&NR=2017119667A |
| ParticipantIDs | epo_espacenet_JP2017119667A |
| PublicationCentury | 2000 |
| PublicationDate | 20170706 |
| PublicationDateYYYYMMDD | 2017-07-06 |
| PublicationDate_xml | – month: 07 year: 2017 text: 20170706 day: 06 |
| PublicationDecade | 2010 |
| PublicationYear | 2017 |
| RelatedCompanies | KEIO GIJUKU TAIYO NIPPON SANSO CORP |
| RelatedCompanies_xml | – name: TAIYO NIPPON SANSO CORP – name: KEIO GIJUKU |
| Score | 3.1560733 |
| Snippet | PROBLEM TO BE SOLVED: To provide a medicinal composition that is capable of improving the prognosis after the return of spontaneous circulation even after the... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| Title | MEDICINAL COMPOSITION FOR IMPROVING PROGNOSIS AFTER RETURN OF SPONTANEOUS CIRCULATION |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170706&DB=EPODOC&locale=&CC=JP&NR=2017119667A |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dS8NALMwp6ptORZ3KIdK34vqxdj4M6a7t1rHelX6MvY22tqDCNlzFv296burTnu4jEO5CcrnkkhzAA2ooPdNMTX56SQtZV7NS7pWlIiumohRmUaY_tfR8ZowSfTzrzhrwvs2FEXVCv0RxRJSoHOW9Euf16s-JZYvYyvVj9opTy2c37tvSxjpWTORgQ7IHfSfgNqcSpf1xILFQwBTkNsO09mBf7WpGHf_nTAd1Wsrqv05xT-AgQHSL6hQab2kLjuj267UWHPqbF2_sboRvfQaJKMXoMWtCKPcDHnm1e4mgGUc8Pwj51GNDgu2QISgilos3VRI6cRIywl0SBZzFFnN4EhHqhTSZCPfUOdy7TkxHMq5v_kuN-Tj4txftApqL5aK4BNIxsrybp70ULSq9UFPUw7nSKXS8smRqp6dfQXsHouud0DYc1yMRpmrcQLP6-CxuURlX2Z0g4jcDz4Z_ |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dT8Iw8IJoxDdFjYofjTF7W9xgbPhAzNgHDLd22QfhjWxzS9QEiMz4971VUJ54atNLLu3lrvfRuyvAA2ooJe1oHfHpNclFpZ0WYq8oZFHWZDnX8iL57aXnUXUUK-Npd1qDj00tDO8T-s2bI6JEZSjvJb-vl_9BLJPnVq4e0zdcWjzbUd8U1t6xrCEHq4I56Fs-M5khGEZ_7As04DAZuU3V9D3YR6GSqvw_azKoylKW2zrFPoYDH9HNyxOovSdNaBibr9eacOitX7xxuha-1SnEvBWjQ3WXGMzzWehU4SWCbhxxPD9gE4cOCY5DiqCQ6DZaqiSwojighNkk9BmNdGqxOCSGExixy8NTZ3BvW5ExEnF_sz9qzMb-1lk651CfL-b5BRBJTbNulvQS9KiUvJ2gHs5kKVfQZEnbUk-5hNYORFc7oXfQGEWeO3Md-tKCowrCU1bVa6iXn1_5DSrmMr3lBP0BcqCJaQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=MEDICINAL+COMPOSITION+FOR+IMPROVING+PROGNOSIS+AFTER+RETURN+OF+SPONTANEOUS+CIRCULATION&rft.inventor=TAMURA+TOMOTAKA&rft.inventor=SANO+MOTOAKI&rft.inventor=SUZUKI+AKIRA&rft.inventor=HAYASHIDA+TAKASHI&rft.inventor=NISHIWAKI+YOSHIKI&rft.date=2017-07-06&rft.externalDBID=A&rft.externalDocID=JP2017119667A |